AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Healthy subjects 18 years of age or older
✓. Lesion is biopsy-proven superficial BCC \<= 2.0 cm in largest diameter
✓. BCC is on trunk or extremities
✓. Seeks and is scheduled for treatment of BCC
✓. Willing to have photographs taken of the treatment area
✓. Ability to understand and the willingness to sign a written informed consent document
✓. Agrees to adhere to the treatment and follow-up schedule and post treatment care instructions
Exclusion criteria
✕. Subjects with a BCC lesion that requires excision. This would include relatively larger lesions (\>2.0 cm in diameter), high risk lesions as defined by American Academy of Dermatology as recurrent and sclerosing subtype BCC, or metastases.
✕. Pregnancy
✕. Subjects unable to follow-up for the full 12-months
✕. Subjects not willing to have biopsy taken from the treatment area
✕. Subjects with herpes simplex virus infection, impetigo or other disqualifying condition as determined by a dermatologist on the treatment area or effecting healing or outcome